InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-19.4%
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the complete record of transactions filed by COOPER GRAHAM K, Directeur. Insider active across 1 company, notably Beam Therapeutics Inc.. Aggregated, 4 reports have been recorded. Activity tracked since 28 June 2021. The latest transaction was disclosed on 6 July 2021 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Declarations4 total
2,614 shares@ US$17.009.0% of flowCommon StockSEC:0000899243-21-027902
2,614 shares@ US$17.000.0013% mcap9.0% of flowCommon StockSEC:0000899243-21-027902:0
12,045 shares@ US$17.000.0060% mcap41.0% of flowCommon StockSEC:0000899243-21-026782:0
12,045 shares@ US$17.0041.0% of flowCommon StockSEC:0000899243-21-026782
4 of 4 declarations
About COOPER GRAHAM K
Graham K. Cooper is a Director at Beam Therapeutics Inc. He plays a key role in the governance of the company, bringing his expertise to guide strategic decisions.
